672296-75-2

Upstream product

• 479673-58-0 (Z)-(2S,3S,4S)-15-(tert-Butyl-dimethyl-silanyloxy)-3-(4-methoxy-benzyloxy)-2,4-dimethyl-pentadec-5-en-1-ol 
• 112-47-0 1,10-Decanediol 
• 90934-00-2 10-(tert-butyldimethylsilyl)oxydecan-1-ol 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 139670-36-3 10-(tert-butyldimethylsilanyloxy)decanal 
• 479673-37-5 (2S)-2-[(4R,5S)-2-(4-methoxyphenyl)-5-methyl[1,3]dioxan-4-yl]propan-1-ol 
• 183565-25-5 (R)-4-Benzyl-3-[(2R,3S,4S)-5-(tert-butyl-dimethyl-silanyloxy)-3-hydroxy-2,4-dimethyl-pentanoyl]-oxazolidin-2-one 
• 479673-44-4 tert-Butyl-{(Z)-(S)-12-[(4S,5S)-2-(4-methoxy-phenyl)-5-methyl-[1,3]dioxan-4-yl]-tridec-10-enyloxy}-dimethyl-silane 

Downstream Products

• 479673-26-2 (12S, [13S,] [14S,] [19R,] [20R,] [21R,] 22S)-21-(TERT-BUTYLDIMETHYLSILANYLOXY)-13,19-[BIS-(4-METHOXYBENZYLOXY)-12,] 14,20, 22-tetramethylhexacosa-10,15, 23, 25-TETRAEN-1-(TERT-Butyldimethylsilanyl)-ol 
• 479673-47-7 (11Z,16Z)-(13S,14S,15S,20R,21S,22S)-14,20-Bis-(4-methoxy-benzyloxy)-13,15,21-trimethyl-22-((Z)-(S)-1-methyl-penta-2,4-dienyl)-oxacyclodocosa-11,16-dien-2-one 
• 479673-46-6 (10Z,15Z,23Z)-(12S,13S,14S,19R,20R,21S,22S)-21-Hydroxy-13,19-bis-(4-methoxy-benzyloxy)-12,14,20,22-tetramethyl-hexacosa-10,15,23,25-tetraenoic acid 
• 479673-45-5 (10Z,15Z,23Z)-(12S,13S,14S,19R,20S,21S,22S)-21-(tert-Butyl-dimethyl-silanyloxy)-13,19-bis-(4-methoxy-benzyloxy)-12,14,20,22-tetramethyl-hexacosa-10,15,23,25-tetraen-1-ol 

Relevant academic research and scientific papers

ANALOGS OF DISCODERMOLIDE AND DICTYOSTATIN-1, INTERMEDIATES THEREFOR AND METHODS OF SYNTHESIS THEREOF

A compound of the following structure: wherein R1 is H, an alkyl group, an aryl group, an alkenyl group, an alkynyl group, or a halogen atom; R2 is H, an alkyl group, an aryl group, a benzyl group, a trityl group, -SiRaRbRc, CH2ORd, or CORe; Ra, Rb and Rc are independently an alkyl group or an aryl group; Rd is an alkyl group, an aryl group, an alkoxylalkyl group, -RiSiRaRbRc or a benzyl group, wherein Ri is an alkylene group; Re is an alkyl group, an allyl group, a benzyl group, an aryl group, an alkoxy group, or -NRgRh, wherein Rg and Rh are independently H, an alkyl group or an aryl group; R3 is (CH2)n where n is and integer in the range of 0 to 5, -CH2CH(CH3)-, -CH=CH-, -CH=C(CH3)-, or -C=-C-; R4 is (CH2)p where p is an integer in the range of 4 to 12, -(CHRkl)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5C(Rsl )=C(Rs2)C(Rs3)=C(Rs4)-, -(CHRk1 )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(RsI)CH(Rs2)C(Rs3)=C(Rs4)-, -(CHRk1)yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRks)y5C(Rsl)=C(Rs2)CH(Rs3)CH(Rs4)-, -(CHRkI )yl (CHRk2)y2(CHRk3)y3(CHRk4)y4(CHRk5)y5CH(Rsl)CH(Rs2)CH(Rs3)CH(R s4)-,wherein y1 and y2 are 1 and y3, y4 and y5 are independently 0 or 1, Rk1, Rk2, Rk3, Rk4 and Rk5 are independently H, CH3, or OR2a, and Rs1,Rs2, Rs3, and Rs4 are independently H or CH3, wherein R2a is H, an alkyl group, an aryl group, a benzyl group, a trityl group, -SiRaRbRc, CH2ORd, or CORe; and R5 is H or OR2b, wherein R2b is H, an alkyl group, an aryl group, an aryl group, a benzyl group, a trityl group, -SiRaRbRc, CH2ORd, or CORe; provided that the compound is not dictyostatin 1.

Discodermolide/Dictyostatin Hybrids: Synthesis and Biological Evaluation

(Matrix Presented) Two hybrid analogues of discodermolide and dictyostatin (3, 26) have been designed and synthesized. These are the first macrocyclic analogues of discodermolide and biological activities were evaluated and compared with linear discodermolide analogues.